United States · 
What does New Leaf Venture Partners invest in?
New Leaf Venture Partners invests most often at Series B and Venture (50% of the rounds on record), in sectors such as Well-being, E-health and Healthcare.
New Leaf Venture Partners highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Venture: 50% of its rounds
- 03
Sole investor in 3 rounds, median $27M
- 04
10 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Well-beingE-healthHealthcare
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first110 appearances
- 2026
1 round
- Oct
- 2019
3 rounds
- Nov
- Sept
- Aug
- 2018
1 round
- Aug
- 2015
13 rounds
- Dec
- Oct
- Sept
- Sept
- Aug
- Aug
- Jul
- Jun
- Jun
- Apr
- Apr
- Apr
- Jan
- 2014
6 rounds
- Dec
- May
- Apr
- Apr
- Feb
- Jan
- 2013
9 rounds
- Oct
- Jul
- Jul
- Jun
- Apr
- Apr
- Mar
- Feb
- Jan
- 2012
20 rounds
- Nov
- Nov
- Nov
- Oct
- Oct
- Oct
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
CLCraig Lawrence SlutzkinChief Operating Officer, Chief Financial Officer, Chief Compliance OfficeriForm ADV
RMRonald Martin HuntManaging DirectoriForm ADV
VKVijay Kiran LathiManaging DirectoriForm ADV
We also hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$408Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- NEW LEAF Venture Partners LLC
- SEC number
- CRD 163897
Funds on its Form ADV
9 private funds, $654M in gross assets · filed Mar 2024
- New Leaf Ventures III, L.P.Venture34 investors$179M
- New Leaf Ventures IV, L.P.Venture15 investors$160M
- New Leaf Biopharma Opportunities II, L.P.Venture9 investors$130M
- NLV-II SPV-2, L.P.Venture2 investors$79M
- NLV-II SPV-1, L.P.Venture14 investors$78M
- New Leaf Biopharma Opportunities I, L.P.Venture2 investors$10.0M
- NLV Co-Invest III, LLCVenture1 investor$9.1M
- NLV Co-Invest II, LLCVenture3 investors$5.3M
- New Leaf Ventures I, L.P.Venture46 investors$3.9M
Exits from the portfolio
Companies it backed that were later bought or listed10 in all
Synageva BioPharmaBought by Alexion Pharmaceuticals$8.4BMay 2015
Convergence PharmaceuticalsBought by Biogen Idec$675MJan 2015
Access ClosureBought by Cardinal Health$320MApr 2014
StromedixBought by Biogen Idec$750MFeb 2014
Oxford ImmunotecListed$64MNov 2013
Karyopharm TherapeuticsListedUndisclosedNov 2013
Pearl TherapeuticsBought by AstraZeneca$1.1BJun 2013
Artisan PharmaBought by Asahi Kasei PharmaUndisclosedNov 2011
Interlace MedicalBought by Hologic$125MJan 2011
VisiogenBought by Abbott Labs$400MSept 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.